ATA Revises Pregnancy Thyroid Guidelines After Nine Years

Originally surfaced June 10, 2026, drawing on American Thyroid Association guidance published June 3, 2026.

The American Thyroid Association published its first major revision to thyroid testing guidelines for pregnancy on June 3, 2026, nine years after the prior version was released. The document, developed by an international task force representing ten professional societies, covers thyroid evaluation and management from preconception through the postpartum period.

The most notable shift is a more conservative approach to mildly abnormal results. Under the updated framework, a single mildly elevated TSH is not considered sufficient to start levothyroxine therapy. The guidelines recommend confirming the finding with a repeat test first, because a meaningful portion of people with borderline TSH results show a normal reading on retesting. That principle applies to both subclinical hypothyroidism, meaning elevated TSH with normal thyroid hormone levels, and mild overt hypothyroidism.

TSH, or thyroid-stimulating hormone, remains the recommended first test for assessing thyroid function. It is produced by the pituitary gland and serves as the most sensitive signal of whether the thyroid is working within its normal range. When TSH falls outside normal, the guidelines recommend adding a free T4 measurement to clarify the picture, since free T4 reflects how much active thyroid hormone is circulating.

The guidelines include a note relevant to anyone interpreting thyroid results: free T4 levels measured by standard immunoassay can be less reliable in certain physiological states because changes in blood-binding proteins shift reported values. The ATA task force said clinicians should understand the limitations of the specific assay their lab uses and avoid over-interpreting borderline free T4 readings when the clinical picture does not support them.

The role of thyroid peroxidase, or TPO, antibody testing also received attention. TPO antibodies are markers of autoimmune activity directed at the thyroid. Their presence at elevated levels, even when TSH is normal, can signal a higher long-term risk of developing thyroid dysfunction. The 2026 guidelines reinforce that a positive TPO antibody result on its own is not a reason to start thyroid medication. The recommendation is monitoring instead, with thyroid function checks at intervals if antibodies are detected in someone whose TSH is otherwise normal.

TSH testing and thyroid antibody testing are both available at LabTestSuperstore: the TSH test and thyroid antibodies test. Background pages on thyroid symptoms, hypothyroidism, and Hashimoto's disease provide broader context on how thyroid labs are commonly discussed.

What this update does not mean

These guidelines are written specifically for clinicians managing thyroid disease in patients preparing for pregnancy, during pregnancy, and in the postpartum period. The testing principles described here, including TSH as the primary test, repeat testing before treatment, and TPO antibody monitoring, exist within a supervised clinical relationship, not a self-directed testing context.

The guidelines do not recommend routine thyroid screening for asymptomatic adults in the general population, and they do not establish specific TSH or free T4 values that any individual should try to achieve on their own. A person reviewing their own thyroid results should work with a clinician who has access to their full history, not apply thresholds drawn from guidelines written for a different population and setting.

The ATA task force also noted limits in the available data, pointing out that population-specific and trimester-specific TSH reference ranges are not uniformly available across all labs, and called for better standardization as a research priority.

This article is editorial commentary and is not medical advice. Decisions about thyroid testing, pregnancy, thyroid antibodies, or thyroid medication should be made with a qualified clinician who can interpret results in context.